Back to Search
Start Over
Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- BACKGROUND AND AIMS Non-alcoholic fatty liver (NAFLD) is a major cause of liver disease worldwide leading also to a higher risk of cardiovascular events. We aimed to evaluate the impact of fatty liver and fibrosis on cardiovascular risk in a general population. METHODS Five hundred and forty-two subjects included in the community-based ABCD (Alimentazione, Benessere Cardiovascolare e Diabete) study were recruited. Steatosis (controlled attenuation parameter > 288 dB/m) and severe fibrosis (low risk, liver stiffness measurement [LSM]
- Subjects :
- Adult
cardiovascular risk
medicine.medical_specialty
Population
Gastroenterology
Asymptomatic
03 medical and health sciences
Liver disease
0302 clinical medicine
atherosclerosi
Non-alcoholic Fatty Liver Disease
Fibrosis
Internal medicine
NAFLD
medicine
Humans
Settore MED/49 - Scienze Tecniche Dietetiche Applicate
education
education.field_of_study
Settore MED/12 - Gastroenterologia
Hepatology
business.industry
Fatty liver
Confounding
Odds ratio
medicine.disease
carotid
Cardiovascular Diseases
Heart Disease Risk Factors
030220 oncology & carcinogenesis
ABCD study
fatty liver disease
030211 gastroenterology & hepatology
Steatosis
medicine.symptom
business
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....e04f182aafc839e44df99084d3cdb10c